Collagen synthesis stimulation via photobiomodulation pathways

Collagen synthesis stimulation via photobiomodulation pathways does not refer to a single molecular target such as a receptor or enzyme. Instead, it describes a biological process whereby exposure to specific wavelengths of light—commonly red or near-infrared—modulates cellular activity in skin fibroblasts and other cells. This process is known as photobiomodulation (PBM), previously called low-level laser/light therapy (LLLT). PBM acts primarily through absorption of photons by mitochondrial cytochrome c oxidase and possibly gated ion channels. This leads to increased ATP production and altered reactive oxygen species levels, which then activate transcription factors such as NF-kB. The downstream effects include enhanced cell proliferation, migration, differentiation, and upregulation of genes involved in extracellular matrix formation—including various types of collagens—as well as modulation of metalloproteinases and their inhibitors[1][2][3]. PBM has been shown to increase the number of fibroblasts and stimulate the production of type I and III collagens without significant side effects when used appropriately[1]. However, there are concerns about its use in cancer patients due to potential risks related to tumor growth promotion if parameters are not carefully controlled[2]. The "target" here is thus an entire signaling cascade/process rather than an individual molecular entity. Because this entry refers broadly to a physiological response induced by physical energy input—not a discrete druggable target—it should be flagged as "incorrect" for structured therapeutic target databases that require specific molecules like receptors or enzymes. References supporting these statements can be found throughout the provided search results.[1][2][3]

Other names

Photobiomodulation-induced collagen synthesisPBM-mediated collagen productionLight therapy–stimulated collagen synthesisLow-level laser therapy (LLLT)–induced collagen production